healthcare

Max Healthcare

MAXHEALTH · Nifty 50

1,026.15

Price 2026-06-17

BROAD EXPANSION73% confidence

At a Glance

ValuationPE 68.5 (22%ile of 5Y range 56-101). Trading below historical range.
Sector Positionhealthcare sector. Flow: neutral. is not among current leaders. Regime: BROAD EXPANSION (73%).
Fundamental Score85/100 (STRONG). 1 positive flags, 2 concerns.
Historical Context60 similar technical setups. Average outcome: -8.5% decline. 0% positive.
Revenue TrendRevenue growing at 12.2% YoY. Moderate revenue growth — 12.2% YoY

Fundamental

85/100

STRONG

Trust

95/100

Verification

Coverage

89/100

HIGH

Quick Take

Max Healthcare scores 85/100 on fundamentals (strong). Max Healthcare: PE below historical average. BROAD EXPANSION regime.

Fundamental Score: 85/100 · STRONG · 0 signals detected

DuPont Analysis

ROE 13.4% broken into three drivers. Each shows how efficiently the company generates returns.

ROE13.4%=
17.2%Net Margin
×
0.5xTurnover
×
1.6xLeverage

ROE of 13.43% is moderate margin-driven and stable. Net margin of 17.2% × asset turnover of 0.49x × leverage of 1.6x.

What This Means

Net margin of 17.2% means the company keeps ₹17.2 as profit for every ₹100 of revenue. This is a healthy margin. Asset turnover of 0.49x means the company generates ₹0.49 of revenue for every ₹1 of assets. This is a capital-heavy business. Leverage of 1.6x means the company uses moderate debt. Returns are primarily driven by operations, not borrowing.

Margin Structure

Gross

78.6%

Operating

22.8%

Net

17.2%

improving

Gross margin 78.6% → operating margin 22.8% → net margin 17.2%. Margins are IMPROVING. Strong pricing power with stable gross margins suggests the improvement is from operating leverage — sustainable.

Financial Health

Earnings Quality

ADEQUATE

Cash flow covers net income 1.1x — earnings are ADEQUATE quality. Cash conversion is reasonable.

Debt Sustainability

COMFORTABLE

Interest covered 8.1x — very comfortable. Debt service is not a concern. Debt/EBITDA at 1.5x is low — balance sheet has capacity.

Free Cash Flow

MODERATE

FCF margin at 1.8% — barely positive. Limited cash after capex.

Peer Comparison

Max Healthcare is compared against 5 peers in the healthcare sector.

Key Watchpoints

🟢

Breaks above ₹1077 (+5%)

Trend reversal confirmation

🔴

Breaks below ₹975 (-5%)

Further downside risk

🟡

PE reverts to 5Y median of 68.7

Valuation normalization

🟢

Healthcare sector entering leadership

Sector rotation signal

Risk Flags

⚠️ 2 Warning1 Positive3 total flags
⚠️Cash covers 30% of current liabilities
Balance Sheet

Tight liquidity. Monitor cash position and access to credit lines.

⚠️Price/Sales: 12.7x — expensive on revenue basis
Valuation

High revenue multiple. Market pricing in significant growth or margins expansion.

Minimal unusual items — clean earnings
Earnings Quality

Profits are from core operations, not one-offs. High quality.

➡️ 3 flags — 1 positive, 2 warning. Mixed profile.

Data Quality

95/100All ratios self-computed from verified sources. 🟢 5 years of financial data — sufficient for trend analysis

News Correlation

margin pressure (4)management outlook (4)
⚠️ Our margin analysis (improving) contradicts news reports of margin pressure — investigate

50 articles scanned for fundamental themes

Facts

P/E Ratio
68.5HIGH
P/B Ratio
9.2HIGH
ROE
14.3%HIGH
Market Cap
₹9853607.0L CrHIGH
From 52W High
78% of high
Promoter Holding
27.1%MODERATE
Institutional
63.1%
Sector Peers
5
Max Healthcare Stock Analysis, Valuation, Fundamentals & Intelligence | FynSight